Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Description of plasma concentrations of perfluoroalkyl substances stratified by sex

From: Individual and mixture associations of perfluoroalkyl substances on liver function biomarkers in the Canadian Health Measures Survey

 

Males

Females

na

GM (SE)

na

GM (SE)

PFOA (µg/L)

2288

2.2 (0.06)

2365

1.7 (0.05)

PFOS (µg/L)

2288

7.2 (0.26)

2366

4.6 (0.16)

PFHxS (µg/L)

2287

2.2 (0.09)

2365

1.1 (0.05)

PFNA (µg/L)

973

0.67 (0.03)

929

0.64 (0.03)

PFDA (µg/L)

948

0.20 (0.01)

928

0.19 (0.01)

PFUDA

na

%b

na

%b

 < LOD

454

53

414

45

 LOD – 75th percentile

306

24

319

32

 > 75th percentile

230

23

225

23

  1. GM Geometric mean, SE Standard error, LOD Limit of detection
  2. aSample sizes differ as a result of combining different cycles of the Canadian Health Measure Survey based on data availability
  3. bpercent within column, calculated using sample weights